Tue, June 12, 2012
Mon, June 11, 2012
Sat, June 9, 2012
Fri, June 8, 2012
Thu, June 7, 2012
Wed, June 6, 2012
Tue, June 5, 2012
Mon, June 4, 2012
Sat, June 2, 2012
Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012

Jazz Pharmaceuticals Announces Presentation At The Jefferies 2012 Global Healthcare Conference In New York On June 7


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. healthcare-conference-in-new-york-on-june-7.html
  Print publication without navigation Published in Health and Fitness on by Market Wire


Jazz Pharmaceuticals Announces Presentation At The Jefferies 2012 Global Healthcare Conference In New... -- DUBLIN, June 5, 2012 /PRNewswire/ --

Jazz Pharmaceuticals Announces Presentation At The Jefferies 2012 Global Healthcare Conference In New York On June 7

[ ]

DUBLIN, June 5, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: [ JAZZ ]) announced today that the company will make a presentation at the Jefferies 2012 Global Healthcare Conference in New York on Thursday, June 7, 2012 at 8:00 a.m. EST/ 1:00 p.m. GMT. Bruce Cozadd, Chairman and Chief Executive Officer, will provide a business update.

A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at [ www.jazzpharmaceuticals.com ]. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archived version of webcast will be available for at least one week on the Investors section of the company's website at [ www.jazzpharmaceuticals.com ].

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc (Nasdaq: [ JAZZ ]) is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing products that address unmet medical needs.  The company has a diverse portfolio of products in the areas of narcolepsy, chronic pain, psychiatry and women's health.  The company's marketed products in include: Xyrem® (sodium oxybate), Prialt® (ziconotide intrathecal infusion), FazaClo® (clozapine USP) HD and LD, Luvox CR® (fluvoxamine maleate) and Elestrin® (estradiol gel 0.06%).

 

SOURCE Jazz Pharmaceuticals plc

[ Back to top ]

RELATED LINKS
[ http://www.jazzpharmaceuticals.com ]


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear